AEON BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.58 USD | +9.72% |
|
-11.24% | -78.06% |
| May. 16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
| May. 16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
Evolution of the average Target Price on AEON Biopharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
f7a9ec6ad296f5ce0af81.NM_nXCW0dJv9K1CpRNZmToiwgm6ul5NqKPxCteFN2wo.XYqjCU3VDaqMcn3LEbQePPLbtj3rr-orHMUHxaUrnVwNpYU7S99F2qxHNw~104426da9166ba85b7d1bbf96d65f9dd
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.58
USD
Average target price
6
USD
Spread / Average Target
+279.75%
High Price Target
6
USD
Spread / Highest target
+279.75%
Low Price Target
6
USD
Spread / Lowest Target
+279.75%
Consensus detail
Consensus revision (last 18 months)
Analysts covering AEON Biopharma, Inc.
| HC Wainwright |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AEON Stock
- Consensus AEON Biopharma, Inc.
